PUBLIC CONTRACT · 2018
Crizotinib 250 mg cáps - Aumento de consumo - 1o semestre
- Contract value
- €141,780.24
- Signed on
- 2 March 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4334122PUBLISHED DESCRIPTION
BEAD20180124- CRIZOTINIB 250 MG CÁPS - AUMENTO DE CONSUMO - 1o SEMESTRE
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PFIZER BIOFARMACEUTICA · Tax ID 513300376
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €141,780.24
- Procedure base price
- €157,533.66
- Total effective price
- €141,780.24
- Publication date
- 8 March 2018
- Award date
- 26 February 2018
- Signing date
- 2 March 2018
- Performance period
- 120 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos e DLR no 34/2008/M, de 14.08
- Framework agreement
- CONCURSO PUBLICO 2015/06 MEDICAMENTOS FORO ONCOLOGICO ABERTO PELA SPMS - P259-AC-21016-165
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3324540
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.